サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1485783

無菌注射剤市場：薬剤タイプ別、用途別、投与経路別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測

Sterile Injectables Market, By Drug Type, By Application, By Route of Administration, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 284 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.88円
無菌注射剤市場：薬剤タイプ別、用途別、投与経路別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

無菌注射剤市場規模は2023年に129億8,254万米ドルとなり、2024年から2032年にかけてCAGR 12.43％で拡大

無菌注射剤市場-市場力学

高齢化と慢性疾患の増加

がん、糖尿病、自己免疫疾患などの慢性疾患の罹患率の上昇は、治療と管理のための無菌注射薬の需要を煽る。加えて、慢性疾患を治療するための新しい技術を革新する製薬会社が増加しており、予測期間中の市場成長を後押ししています。さらに、新規技術のFDAによる承認は、無菌注射薬へのアクセスを向上させています。革新的なライフサイエンスおよび消費者製品企業は、新製品を市場に投入し、それらの製品にラベル付けして販売促進し、FDA（食品医薬品局）の規制と絶えず拡大する進化する法律に従って市販後のコンプライアンスを確保するという複雑な規制をうまく切り抜けなければなりません。

無菌注射剤市場-主要インサイト

リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約12.43%のCAGRで毎年成長すると推定されます。

薬剤タイプ別では、サイトカインが2023年に最大の市場シェアを示すと予測されます。

用途別では、がんが2023年の主要タイプでした。

エンドユーザー別では、バイオ製薬会社が2023年の主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

無菌注射剤市場-セグメンテーション分析：

無菌注射剤の世界市場は、薬剤タイプ、用途、投与経路、エンドユーザー、地域に基づいてセグメント化されます。

市場は用途に基づいて7つのカテゴリーに分けられる：がん、糖尿病、心血管疾患、中枢神経系疾患、感染症、筋骨格系、その他。がん治療では、化学療法薬を血流に直接投与するために無菌注射剤が一般的に使用されます。これらの薬剤は全身を循環し、がん細胞を標的として破壊します。ある種のGLP-1受容体作動薬など、糖尿病を管理するために使用される薬剤の中には、無菌注射剤を介して投与されるものもあります。

市場はエンドユーザーによって2つのカテゴリーに分けられる：無菌注射剤は、製薬会社やバイオ医薬品会社において、薬物を血流や組織に直接投与するために重要な役割を果たしています。バイオ医薬品企業では、モノクローナル抗体、ワクチン、細胞療法などの生物学的薬剤のデリバリーに無菌注射剤が使用されます。

無菌注射剤市場-地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

アジア太平洋地域は、アジア諸国におけるコスト削減の機会や、インドや中国における支持的な規制政策により、最も魅力的な市場となっています。さらに、中国国内のバイオ医薬品・製薬会社がこの地域の市場成長を支えています。無菌注射剤のメーカーは、無菌注射剤の製品ポートフォリオを拡大するために、合併や買収を含む戦略を採用しています。また、製薬会社やライフサイエンス企業による研究開発投資の増加は、将来的に無菌注射剤の需要を増加させると思われます。

無菌注射剤市場-競合情勢：

無菌注射剤を開発する新興国市場は、無菌注射剤の製品ポートフォリオを拡大するためにM&Aなどの戦略を採用しており、予測期間にわたって世界の無菌注射剤市場の成長を後押しすると予想されます。Baxter社、Catalent社、Vetter Pharma社、Recipharm AB社、Aenova Group社、Fresenius Kabi社、Famar社などの大手企業は、最新の市場動向や製造プロセスの改善を含む技術の進歩に従い、世界の事業における地位を固めています。

目次

第1章 無菌注射剤市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 無菌注射剤の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 無菌注射剤産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 無菌注射剤市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 無菌注射剤市場情勢

  • 無菌注射剤市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 無菌注射剤市場：薬剤タイプ別

  • 概要
    • セグメントシェア分析
    • モノクローナル抗体（mAbs）
    • サイトカイン
    • インスリン
    • ペプチドホルモン
    • ワクチン
    • 免疫グロブリン
    • その他

第8章 無菌注射剤市場：用途別

  • 概要
    • セグメントシェア分析
    • がん
    • 糖尿病
    • 心血管疾患
    • 中枢神経系疾患
    • 感染症
    • 筋骨格
    • その他

第9章 無菌注射剤市場：投与経路別

  • 概要
    • セグメントシェア分析
    • 皮下（SC）
    • 静脈内（IV）
    • 筋肉内（IM）

第10章 無菌注射剤市場：エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 製薬会社
    • バイオ医薬品企業

第11章 無菌注射剤市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：無菌注射剤業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Baxter
    • Catalent, Inc.
    • Vetter Pharma
    • Recipharm AB
    • Aenova Group
    • Fresenius Kabi
    • Unither Pharmaceuticals
    • Famar
    • Cipla Inc.
    • NextPharma Technologies
    • その他

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Sterile Injectables Market: Drug Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Sterile Injectables Market, by Drug Type 2019-2032 (USD Million)
  • TABLE Sterile Injectables Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Sterile Injectables Market, by Application 2019-2032 (USD Million)
  • TABLE Sterile Injectables Market: Route Of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route Of Administration
  • TABLE Global Sterile Injectables Market, by Route Of Administration 2019-2032 (USD Million)
  • TABLE Sterile Injectables Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Sterile Injectables Market, by End User 2019-2032 (USD Million)
  • TABLE Sterile Injectables Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Sterile Injectables Market, by Region 2019-2032 (USD Million)
  • TABLE North America Sterile Injectables Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Sterile Injectables Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE North America Sterile Injectables Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Sterile Injectables Market, by Route Of Administration, 2019-2032 (USD Million)
  • TABLE North America Sterile Injectables Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Sterile Injectables Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Sterile Injectables Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Europe Sterile Injectables Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Sterile Injectables Market, by Route Of Administration, 2019-2032 (USD Million)
  • TABLE Europe Sterile Injectables Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sterile Injectables Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sterile Injectables Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sterile Injectables Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sterile Injectables Market, by Route Of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sterile Injectables Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Sterile Injectables Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Sterile Injectables Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Latin America Sterile Injectables Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Sterile Injectables Market, by Route Of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Sterile Injectables Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sterile Injectables Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sterile Injectables Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sterile Injectables Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sterile Injectables Market, by Route Of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sterile Injectables Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2682

REPORT HIGHLIGHT

Sterile Injectables Market size was valued at USD 12,982.54 Million in 2023, expanding at a CAGR of 12.43% from 2024 to 2032.

Sterile injectables are medications and other therapeutic products that are administered directly into the bloodstream or tissues of the body. As the global population ages, there's a greater demand for injectable medications, particularly for conditions prevalent in older adults such as arthritis, cardiovascular diseases, and neurological disorders. However, regulatory approvals for sterile injectable drugs are stringent due to safety concerns associated with injectable formulations. Meeting these requirements can be time-consuming and costly, hindering market growth. Furthermore, advances in drug delivery systems and techniques, such as prefilled syringes and auto-injectors, enhance patient convenience, compliance, and safety, thereby driving the demand for sterile injectable products.

Sterile Injectables Market- Market Dynamics

Increasing aging population and prevalence of chronic diseases

The rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders fuels the demand for sterile injectable medications for treatment and management. In addition, an increase in several pharmaceutical companies are innovating novel techniques to treat chronic diseases, leading to fueling the market growth over the forecasting period. Additionally, approval by the FDA for novel techniques is improving access to sterile injectables. Innovative life sciences and consumer product companies must successfully navigate the regulatory complexities of introducing new products to the market, labeling and promoting those products, and ensuring post-marketing compliance with the Food and Drug Administration (FDA) regulations and an ever-expanding body of evolving laws.

Sterile Injectables Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.43% over the forecast period (2024-2032)

Based on drug type segmentation, Cytokines was predicted to show maximum market share in the year 2023

Based on application segmentation, Cancer was the leading type in 2023

Based on end-user segmentation, Biopharmaceutical Companies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Sterile Injectables Market- Segmentation Analysis:

The Global Sterile Injectables Market is segmented on the basis of Drug Type, Application, Route of Administration, and End User and Region.

The market is divided into seven categories based on application: Cancer, diabetes, cardiovascular diseases, central nervous system diseases, infectious disorders, musculoskeletal, and Others. In cancer treatment, sterile injectables are commonly used to administer chemotherapy drugs directly into the bloodstream. These drugs circulate throughout the body, targeting and destroying cancer cells. Some medications used to manage diabetes, such as certain types of GLP-1 receptor agonists, are administered via sterile injectables.

The market is divided into two categories based on end-user: Sterile injectables play a crucial role in pharmaceutical and biopharmaceutical companies for delivering medications directly into the bloodstream or tissues. In biopharmaceutical companies, sterile injectables are used for the delivery of biological drugs, such as monoclonal antibodies, vaccines, and cell therapies.

Sterile Injectables Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Asia Pacific is the most attractive market due to cost-saving opportunities in Asian countries and supportive regulatory policies, in India and China. In addition, China's domestic biopharmaceutical & pharmaceutical companies a supporting the region's market growth. Manufacturers of sterile injectables are adopting strategies including mergers and acquisitions, to expand their sterile injectables product portfolio. In addition, increasing R&D investments by pharmaceutical companies and life sciences will increase demand for sterile injectables in the future.

Sterile Injectables Market- Competitive Landscape:

Manufacturers developing sterile injectables are adopting strategies such as mergers and acquisitions, to expand their sterile injectables product portfolio, which is expected to boost the global sterile injectables market growth over the forecast period. Leading players including Baxter, Catalent, Inc., Vetter Pharma, Recipharm AB, Aenova Group, Fresenius Kabi, Famar, etc. are following the latest market trends, and advances in technology including improvements in manufacturing processes to consolidate their position in global businesses.

Recent Developments:

In April 2022, Nevakar Injectables Inc. is a biopharmaceutical company announced that the U.S. Food and Drug Administration ("FDA") has approved its ready-to-use Ephedrine Sulfate Injection which is used for treating patients in the surgical setting.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL STERILE INJECTABLES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Baxter

Catalent, Inc.

Vetter Pharma

Recipharm AB

Aenova Group

Fresenius Kabi

Unither Pharmaceuticals

Famar

Cipla Inc.

NextPharma Technologies

Others

GLOBAL STERILE INJECTABLES MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies (mAbs)
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccines
  • Immunoglobulins
  • Others

GLOBAL STERILE INJECTABLES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Central Nervous System Diseases
  • Infectious Disorders
  • Musculoskeletal
  • Others

GLOBAL STERILE INJECTABLES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Subcutaneous (SC)
  • Intravenous (IV)
  • Intramuscular (IM)

GLOBAL STERILE INJECTABLES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biopharmaceutical Companies

GLOBAL STERILE INJECTABLES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Sterile Injectables Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Sterile Injectables Market Snippet by Drug Type
    • 2.1.2.Sterile Injectables Market Snippet by Application
    • 2.1.3.Sterile Injectables Market Snippet by Route Of Administration
    • 2.1.4.Sterile Injectables Market Snippet by End User
    • 2.1.5.Sterile Injectables Market Snippet by Country
    • 2.1.6.Sterile Injectables Market Snippet by Region
  • 2.2.Competitive Insights

3.Sterile Injectables Key Market Trends

  • 3.1.Sterile Injectables Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Sterile Injectables Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Sterile Injectables Market Opportunities
  • 3.4.Sterile Injectables Market Future Trends

4.Sterile Injectables Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Sterile Injectables Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Sterile Injectables Market Landscape

  • 6.1.Sterile Injectables Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Sterile Injectables Market - By Drug Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
    • 7.1.2.Monoclonal Antibodies (mAbs)
    • 7.1.3.Cytokines
    • 7.1.4.Insulin
    • 7.1.5.Peptide Hormones
    • 7.1.6.Vaccines
    • 7.1.7.Immunoglobulins
    • 7.1.8.Others

8.Sterile Injectables Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Cancer
    • 8.1.3.Diabetes
    • 8.1.4.Cardiovascular Diseases
    • 8.1.5.Central Nervous System Diseases
    • 8.1.6.Infectious Disorders
    • 8.1.7.Musculoskeletal
    • 8.1.8.Others

9.Sterile Injectables Market - By Route Of Administration

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Route Of Administration, 2023 & 2032 (%)
    • 9.1.2.Subcutaneous (SC)
    • 9.1.3.Intravenous (IV)
    • 9.1.4.Intramuscular (IM)

10.Sterile Injectables Market - By End User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Pharmaceutical Companies
    • 10.1.3.Biopharmaceutical Companies

11.Sterile Injectables Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Sterile Injectables Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Sterile Injectables Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Sterile Injectables Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Sterile Injectables Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Sterile Injectables Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Sterile Injectables Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Baxter
    • 12.2.2.Catalent, Inc.
    • 12.2.3.Vetter Pharma
    • 12.2.4.Recipharm AB
    • 12.2.5.Aenova Group
    • 12.2.6.Fresenius Kabi
    • 12.2.7.Unither Pharmaceuticals
    • 12.2.8.Famar
    • 12.2.9.Cipla Inc.
    • 12.2.10.NextPharma Technologies
    • 12.2.11.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us